
Sign up to save your podcasts
Or
Mr. Chet Burrell, former president and CEO of Care First Blue Cross Blue Shield and Executive Chairman of the Intervention Insights Board of Directors, discusses the challenges payers face in managing the growth of precision medicine for cancer care and why he's championing Trapelo's precision diagnostic platform as the first collaborative technology solution.
4.8
3131 ratings
Mr. Chet Burrell, former president and CEO of Care First Blue Cross Blue Shield and Executive Chairman of the Intervention Insights Board of Directors, discusses the challenges payers face in managing the growth of precision medicine for cancer care and why he's championing Trapelo's precision diagnostic platform as the first collaborative technology solution.
38,603 Listeners
43,933 Listeners
8,642 Listeners
32,120 Listeners
43,528 Listeners
1,448 Listeners
9,504 Listeners
9,182 Listeners
316 Listeners
7,999 Listeners
14,310 Listeners
5,409 Listeners
2,099 Listeners
47 Listeners
5 Listeners